Skip to main content
Premium Trial:

Request an Annual Quote

Horizon, Thermo Fisher Sign Marketing Deal

NEW YORK (GenomeWeb) – Horizon Discovery today announced a deal for the marketing of its X-MAN human haploid and diploid isogenic cell line collection by Thermo Fisher Scientific. 

Under the supply and commercialization agreement, Thermo Fisher will also further offer Horizon's X-MAN haploid cell line generation service to its worldwide customer base. Thermo Fisher will use its e-commerce and direct sales channels to make the products and services available to the research community. 

Financial and other terms were not disclosed. 

The X-MAN cell line range is a bank of genetically defined human cell lines that exhibit disease-causing genetics. The models have been highly validated and undergone extensive quality control, Horizon said. The product line includes diploid cell lines and haploid cell lines developed using theCambridge, UK-based firm's proprietary recombinant adeno-associated virus (rAAV) and high-throughput CRISPR gene editing technologies.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.